scholarly journals Аналіз наявних інструментів оцінювання впливу фізичної терапії на осіб з хворобою Паркінсона

2021 ◽  
pp. 84-91
Author(s):  
В. Брушко ◽  
Р. Баннікова ◽  
А. Ковельська
Keyword(s):  
Dual Task ◽  
Berg Balance Scale ◽  
Walk Test ◽  
Walk Distance ◽  
Timed Up And Go ◽  
Sf 36 ◽  
Minute Walk Distance ◽  
Minute Walk ◽  
Disease Questionnaire ◽  
10 Meter Walk Test

Резюме. Правильний і обґрунтований вибір інструментальних методів оцінювання функціо-нального стану пацієнта є обов’язковою умовою адекватної фізичної терапії. Особливе місце цей аспект займає в системі нейрореабілітації пацієнтів з хворобою Паркінсона в Україні, оскільки на сьогодні кількість осіб, що потребують систематичної фізичної терапії, сягає 23 900 тис. Наростаюча маніфестація моторних і немоторних симптомів при хворобі Паркін-сона, від яких часто вирішальною мірою залежить тяжкість стану пацієнта, негативно впливає на якість його життя. Наявні функціональні порушення, які є самостійними проявами хвороби Паркінсона, вимагають специфічного підходу до комплексного інструментального досліджен-ня цих порушень для визначення диференційно-діагностичних критеріїв та оцінювання впливу фізіотерапевтичного втручання. Мета. Проаналізувати наявні інструменти оцінювання впливу фізичної терапії на осіб з хворобою Паркінсона. Методи. Теоретичний аналіз та узагальнення зарубіжних даних спеціальної науково-методичної літератури з питань застосування інстру-ментів оцінювання при хворобі Паркінсона та їх інформативності і надійності у фізичній терапії. Результати. Представлені дані свідчать, що ефективність запроваджених заходів фізичної терапії при хворобі Паркінсона залежить від правильно підібраних інструментів оцінювання, які дозволяють оцінити моторні і немоторні проблеми через призму життєдіяльності і якості життя пацієнта. Основним інструментом оцінювання для вирішення цього питання вважаєть-ся Уніфікована рейтингова шкала хвороби Паркінсона MDS-UPDRS, яка дозволяє об’єктивно оцінити моторні і немоторні аспекти життя пацієнта і його рухову активність. Оскільки наявні моторні й аксіальні рухові порушення негативно впливають на повсякденну функціональну активність пацієнта, для верифікації цих порушень пропонують використовувати тест для оці-нювання часу підйому і ходьби (Timed Up and Go (TUG)); тест з подвійним завданням (Dual-Task TUG (TUG-DT)) та шкалу рівноваги Берга (Berg Balance Scale (BBS)). Але виходячи з того, що ці тести недостатньо чутливі до невеликих змін у рухливості при хворобі Паркінсона, особливо на середніх і пізніх стадіях захворювання, їх доцільно поєднувати з одним із кількісних тестів для оцінювання ходьби: 10-метровим тестом ходьби (10 Meter Walk Test (10MW)) та 6-хвилинним тестом ходьби (Six Minute Walk Distance (6MWT)). Поняття «життєдіяльність» включає в себе не тільки переміщення, її оцінювання має бути доповнено аналізом ступеня впливу наявних по-рушень на повсякденну діяльність, тобто на якість життя пацієнта. Найбільш інформативними інструментами для проведення цього аналізу є універсальні і специфічні при хворобі Паркінсо-на опитувальники з метою оцінювання стану здоров’я SF-36, EuroQOL (EQ-5D) і PDQ-39 (The Parkinson’s Disease Questionnaire). Результати аналізу та узагальнення даних науково-мето-дичної літератури дають підставу встановити, що маніфестація порушень та їх варіабельність при хворобі Паркінсона стають серйозною проблемою у досягненні кінцевого результату за-проваджених заходів фізичної терапії на всіх стадіях захворювання. Використання в комплексі стандартної експертно-реабілітаційної діагностики спеціальних інструментів оцінювання дозволяє об’єктивізувати оцінювання клінічної інформації та стимулює розроблення особисто-орієнтованих реабілітаційних стратегій із застосуванням заходів фізичної терапії, спрямованих на покращення якості життя пацієнтів з хворобою Паркінсона. Ключові слова: хвороба Паркінсона, фізична терапія, якість життя, інструменти оцінювання, достовірність, надійність, валідність.

scholarly journals Repeatability of the Six-Minute Walk Test and Relation to Physical Function in Survivors of a Critical Illness

2012 ◽  
Vol 92 (12) ◽  
pp. 1556-1563 ◽  
Author(s):  
Jennifer A. Alison ◽  
Patricia Kenny ◽  
Madeleine T. King ◽  
Sharon McKinley ◽  
Leanne M. Aitken ◽  
...  
Keyword(s):  
Critical Illness ◽  
Length Of Stay ◽  
Exercise Capacity ◽  
Walk Test ◽  
Walk Distance ◽  
Six Minute Walk Test ◽  
Icu Length Of Stay ◽  
Sf 36 ◽  
Minute Walk Distance ◽  
Minute Walk

Background The Six-Minute Walk Test (6MWT) is widely used as an outcome measure in exercise rehabilitation. However, the repeatability of the 6MWT performed at home in survivors of a critical illness has not been evaluated. Objective The purpose of this study was to evaluate, in survivors of a critical illness: (1) the repeatability of the 6MWT performed at home, (2) the effect on estimates of change in functional exercise capacity if only one 6MWT was performed at follow-up assessments, and (3) the relationship between the physical functioning (PF) score of the 36-Item Short-Form Health Survey questionnaire (SF-36) and the 6MWT. Design Repeated measures of the 6MWT and SF-36 were obtained. Methods Eligible participants had an intensive care unit (ICU) length of stay of ≥48 hours and were mechanically ventilated for ≥24 hours. Two 6MWTs and the SF-36 were conducted in participants' homes at weeks 1, 8, and 26 after hospital discharge. Results One hundred seventy-three participants completed the study. The participants had a mean age of 57 years (SD=16), a mean Acute Physiology and Chronic Health Evaluation II (APACHE II) score on admission of 19 (SD=10), a mean ICU length of stay of 9 days (SD=8), and a mean mechanical ventilation time of 140 hours (SD=137). Of the 173 participants, 110 performed two 6MWTs at weeks 1, 8, and 26. There were significant mean increases in 6-minute walk distance in the second test of 15 m (P<.0001) at week 1, 13 m (P<.0001) at week 8, and 9 m (P=.04) at week 26. If only one 6MWT was performed at weeks 8 and 26, the estimate of change in 6-minute walk distance from week 1 was 19 m less (P<.001) at both weeks 8 and 26. There was a moderate to strong correlation between SF-36 PF score and 6-minute walk distance at each assessment (week 1: r=.62, P<.001; week 8: r=.55, P<.001; and week 26: r=.47, P<.001). Limitations Some study participants were unable to perform a second 6MWT, and these participants may have differed in important aspects of function compared with those individuals who completed two 6MWTs. Conclusions In survivors of a critical illness, the 6MWT in the home environment should be performed twice at each assessment to give an accurate reflection of change in exercise capacity over time. The SF-36 PF score was a strong indicator of 6-minute walk distance in early recovery from a critical illness.

Correlation Between SF-36 and Six-Minute Walk Distance in Liver Donors

2010 ◽  
Vol 42 (9) ◽  
pp. 3597-3599 ◽  
Author(s):  
C.-B. Hsieh ◽  
C.-S. Tsai ◽  
T.-W. Chen ◽  
H.-C. Chu ◽  
J.-C. Yu ◽  
...  
Keyword(s):  
Walk Distance ◽  
Sf 36 ◽  
Minute Walk Distance ◽  
Minute Walk ◽  
Liver Donors

scholarly journals Associations Between Time After Stroke and Exercise Training Outcomes: A Meta‐Regression Analysis

2021 ◽  
Author(s):  
Susan Marzolini ◽  
Che‐Yuan Wu ◽  
Rowaida Hussein ◽  
Lisa Y. Xiong ◽  
Suban Kangatharan ◽  
...  
Keyword(s):  
Exercise Training ◽  
Berg Balance Scale ◽  
Weighted Mean ◽  
Walk Distance ◽  
Mean Values ◽  
Training Interventions ◽  
Meta Regression ◽  
Mean Differences ◽  
Minute Walk Distance ◽  
Minute Walk

Background Knowledge gaps exist regarding the effect of time elapsed after stroke on the effectiveness of exercise training interventions, offering incomplete guidance to clinicians. Methods and Results To determine the associations between time after stroke and 6‐minute walk distance, 10‐meter walk time, cardiorespiratory fitness and balance (Berg Balance Scale score [BBS]) in exercise training interventions, relevant studies in post‐stroke populations were identified by systematic review. Time after stroke as continuous or dichotomized (≤3 months versus >3 months, and ≤6 months versus >6 months) variables and weighted mean differences in postintervention outcomes were examined in meta‐regression analyses adjusted for study baseline mean values (pre‐post comparisons) or baseline mean values and baseline control‐intervention differences (controlled comparisons). Secondary models were adjusted additionally for mean age, sex, and aerobic exercise intensity, dose, and modality. We included 148 studies. Earlier exercise training initiation was associated with larger pre‐post differences in mobility; studies initiated ≤3 months versus >3 months after stroke were associated with larger differences (weighted mean differences [95% confidence interval]) in 6‐minute walk distance (36.3 meters; 95% CI, 14.2–58.5), comfortable 10‐meter walk time (0.13 m/s; 95% CI, 0.06–0.19) and fast 10‐meter walk time (0.16 m/s; 95% CI, 0.03–0.3), in fully adjusted models. Initiation ≤3 months versus >3 months was not associated with cardiorespiratory fitness but was associated with a higher but not clinically important Berg Balance Scale score difference (2.9 points; 95% CI, 0.41–5.5). In exercise training versus control studies, initiation ≤3 months was associated with a greater difference in only postintervention 6‐minute walk distance (baseline‐adjusted 27.3 meters; 95% CI, 6.1–48.5; fully adjusted, 24.9 meters; 95% CI, 0.82–49.1; a similar association was seen for ≤6 months versus >6 months after stroke (fully adjusted, 26.6 meters; 95% CI, 2.6–50.6). Conclusions There may be a clinically meaningful benefit to mobility outcomes when exercise is initiated within 3 months and up to 6 months after stroke.

Functional electrical stimulation as a promising intervention for polymyositis-related weakness: a case report

2021 ◽  
Vol 28 (5) ◽  
pp. 1-8
Author(s):  
Marie Vazquez Morgan ◽  
Suzanne Tinsley ◽  
Rachael Henderson
Keyword(s):  
Electrical Stimulation ◽  
Case Report ◽  
Functional Electrical Stimulation ◽  
Berg Balance Scale ◽  
Functional Mobility ◽  
Walk Test ◽  
Timed Up And Go ◽  
Balance Confidence ◽  
Minute Walk ◽  
Confidence Scale

Background/aims Polymyositis is an inflammatory myopathy characterised by chronic and progressive muscle weakness. This case report discusses a 61-year-old African-American man with polymyositis. Even though pharmacological and physical therapy interventions had previously been prescribed, they had not been beneficial. This case report examined the effects of a functional electric stimulation-assisted exercise programme. Methods The patient was treated in an outpatient clinic two times a week and performed exercises three times a week on alternating days for 36 weeks. In the clinic, he received functional electrical stimulation-assisted strengthening to quadriceps, hamstrings and gluteus maximus while performing activities such as sit to stand, squats, bridging and cycling. For endurance training, he ambulated on the clinic track with a neuroprosthetic to assist with dorsiflexion in the swing phase of gait. At home, he performed lower extremity and core strengthening exercises. Measures to evaluate the intervention included the Manual Muscle Test, functional mobility (Timed Up and Go Test), balance (Berg Balance Scale, Activities of Balance Confidence Scale), endurance (Six-Minute Walk Test with a modified Borg scale) and gait speed (10-Metre Walk Test). Results After 36 weeks of treatment, the patient had made gains in strength in all muscle groups in his bilateral lower extremities except hip extensors. Timed Up and Go time decreased by 14.01 seconds. The patient changed from a medium fall risk to low fall risk on the Berg Balance Scale and his confidence increased by 46.2% on the Activities of Balance Confidence Scale. Furthermore, he gained endurance as exhibited by his increased distance of 289 feet on the Six-Minute Walk Test and his modified Borg score decreased from 4 out of 10 to 2 out of 10. The patient made subjective and objective gains in gait speed, increasing from 0.18 metres per second at his initial examination to 0.50 metres per second. Conclusions This case study demonstrates that functional electrical stimulation-assisted exercise, conducted in an outpatient setting, can improve strength and functional mobility in an individual with polymyositis without detrimental effects.

scholarly journals Improvement of the Six-Minute Walk Test in Children with Sickle Cell Disease over Time

Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 1085-1085
Author(s):  
Geoffrey Bourg ◽  
Laurence Dedeken ◽  
Phu-Quoc Le ◽  
Laurence Rozen ◽  
Safiatou Diallo ◽  
...  
Keyword(s):  
Sickle Cell Disease ◽  
Hemoglobin Level ◽  
Walk Test ◽  
Cell Disease ◽  
Walk Distance ◽  
Six Minute Walk Test ◽  
Clinical Events ◽  
Minute Walk Distance ◽  
Minute Walk ◽  
Over Time

Abstract The six-minute walk test (6MWT) was introduced in adults and children suffering from pulmonary or cardio-vascular conditions to assess their sub-maximal functional exercise capacity. In sickle cell disease (SCD), a reduced 6-minute walk distance was observed in adults with chronic pain, hip avascular necrosis and osteopenia ; and in children with low hemoglobin level, low fetal hemoglobin, a baseline elevated TRV. In a previous study (Dedeken et al., PLoS One 2014), we also showed that abnormal 6MWT was significantly associated with the presence of silent infarct. The aim of our study is to explore the evaluation of the 6MWT over time and to confirm the correlation with the cerebral vasculopathy in a larger cohort. This study was conducted at Hôpital Universitaire des Enfants Reine Fabiola (Brussels, Belgium) and included SCD children older than 6 years, regularly followed between 2011 and 2017 and who had at least two 6MWT. The age-standardized predicted value of the 6-minute walk distance (6MWD) was established as reported by Geiger. The 6MWT was considered as normal if the 6MWD was more than 80% of the age-standardized predicted value. Baseline hematological values, clinical events, cerebro-vascular disease, cardio-pulmonary parameters and disease-modifying treatment (DMT) were compared between those with normal and abnormal 6MWT and according to the 6MWD and between the 1st and the 2nd 6MWT overtime. 118 patients have been assessed twice and had at first evaluation a 6MWD of 90.6% (Range 49-119%), with an abnormal test found in 5.1%. The characteristics of the patients are detailed in the Table 1. The changes of the 6MWD and the biological data over time are detailed in Table 2. After 4 years of follow-up, 77.1% of patients were treated with Hydroxyurea (HU) and 16.6% patients were chronically transfused. In parallel with the increased HU prescribing rate, we have observed a significant increase of the Hb and the MCV and a decrease of reticulocytes and hemolysis parameters. The first 6WMT was performed at the median age of 10.3 years and the last one at the median age of 14.1 years. The median 6MWD increased over time including for non-chronically transfused patients. Girls performed less well in the 6MWT (93% for girls vs. 95.7% for boys; P = 0.03). Acute chest syndrome was significantly more frequent in boys (62%) compare to girls (38.7%). Nevertheless, no other differences were founded between boys and girls regarding biological values, clinical events or DMT. 26.5% of our patients have silent infarcts at a median age of 14.6 years. The 6MWD was the same in patients with and without silent infarcts (92.5% vs. 95% ; P=0.17) even when chronically transfused patients were excluded (94% vs. 95% ; P= 0.20). Patients with silent infarcts have a significant lower hemoglobin level and higher reticulocytes count, neutrophils count, LDH and MCV. In conclusion, the 6MWD observed in our cohort characterized by a very high rate of HU treatment is much higher than published in others series and improved over time. With only 5% of SCD patients having a 6MWD < 80% of the normal predicted value at last evaluation, we were not able anymore to confirm a correlation between the presence of silent infracts and abnormal 6MWT. Disclosures No relevant conflicts of interest to declare.

scholarly journals Six Minute Walk Test as a Monitoring tool in Chronic Obstructive Pulmonary Disease on Pulmonary Rehabilitation

2013 ◽  
Vol 2 (2) ◽  
pp. 35-41
Author(s):  
Vignan Kumar Gali Prakash ◽  
Sujath Gogineni ◽  
Rajesh Kumar ◽  
Mahaboob V Shaik
Keyword(s):  
Pulmonary Rehabilitation ◽  
Forced Expiratory Volume ◽  
Chronic Obstructive ◽  
Walk Test ◽  
Walk Distance ◽  
Obstructive Pulmonary Disease ◽  
Six Minute Walk Test ◽  
The Mean ◽  
Minute Walk Distance ◽  
Minute Walk

Background and Aims- The six minute walk test is widely used as an outcome measure in pulmonary rehabilitation programs. The objective of this study is to report the magnitude of change in the six minute walk test with test repetition in patients with chronic obstructive pulmonary disease on pulmonary rehabilitation program. Methods: A prospective study of 51 patients with moderate to very severe COPD was carried out. Clinical examination, spirometry, six minute walk distance were done. All were advised regular follow up visits at three, six and twelve months. Results: Four (8%) very severe cases completed all visits and one in those showed improvement in Forced Expiratory Volume in 1 second by 6% and six minute walk distance by 71 metres. Seven (31.37%) severe cases completed all visits; showed improvement in Forced Expiratory Volume in 1 second by 2.5%; the distance walked was a mean 381.5 metres and this was 2.5 % improvement over base line walking distance. Six (11%) moderately severe cases completed the study; the mean distance walked at the end of the study was 451 metres, which is an improvement of 53% and the mean change in Forced expiratory volume in 1 second was <2%. Totally, the mean of modified Burden of Lung disease Dyspnoea scale was 1.7 (baseline) and 4 (after the test). Conclusions: These findings support the recommendation of practice six minute walk test at baseline assessment in order to provide an accurate measure of the effects of rehabilitation on six minute walk distance.DOI: http://dx.doi.org/10.3126/jaim.v2i2.8774 Journal of Advances in Internal Medicine 2013;02(02):35-41.

Sign in / Sign up

Export Citation Format

Share Document